Bio-Identical Hormones are Safe and Effective Urges One of the Country’s Leading Bio-Identical Doctors

(PRWEB) November 3, 2006

C. W. Randolph, R. Ph., M.D., a trained pharmacist, a practicing board certified gynecologist, and one of the nation’s leading authorities on bio-identical hormone therapies (BHRT), was recently interviewed by the Wall Street Journal to discuss the safety and effectiveness of bio-identical progesterone cream for treatment of symptoms associated with menopause and PMS. He is the author of the best selling book, “From Hormone Hell to Hormone Well.”

“Over 38 million American women are now entering pre-menopause or menopause and they are seeking alternative solutions to treat the symptoms associated with PMS and menopause,” says Dr. Randolph. “The problem is that medical studies, including the Women’s Health Initiative, have shown that synthetic hormones increase a woman’s risk of heart attacks, stroke, breast and uterine cancer, and Alzheimer’s. Commonly prescribed synthetic hormones such as Premarin or Prempro, are a potential poison to these women and significant changes must be made in the ways these patients are advised and treated by their physicians.”

The issue of safety is a major concern when talking about hormone replacement. In 2002 the Women’s Health Initiative Study (WHI) was halted prior to completion because the synthetic hormones used in that study, namely Prempro and Premarin, were linked to significant health risks including breast and uterine cancers, heart attack, stroke and even Alzheimer’s disease.

Progestin, the molecular compound found in Prempro, is a synthetic drug whose molecular structure is different, thus triggering dangerous side effects in the body. It is important to recognize that bio-identical progesterone is very different from synthetic progestin. Bio-identical progesterone has the same molecular structure as the progesterone produced in the human body and the body recognizes it.

“Bio-identical progesterone is not only safe to use, it can help decrease a woman’s risk for developing cancer,” says Dr. Randolph. “I currently lecture to physicians around the country sharing clinical studies and medical data that validates the fact that bio-identical progesterone has many cancer-protective benefits. The bio-chemistry of why this is so is actually quite simple: progesterone neutralizes the cancer-promoting properties associated with too much estrogen in the body. While estrogen promotes cell proliferation, or cell growth, progesterone decreases cell growth. Too much cell growth is a precursor for cancer.”

“In my gynecology practice, I have prescribed bio-identical progesterone for over a decade and I have never had a patient on my bio-identical hormone regimen develop cancer. I even have patients who are breast cancer survivors who I prescribe bio-identical progesterone because my experience, and the research shows, that the progesterone can play a key role in preventing a recurrence of the original cancer.”

“Obviously, more studies are needed to validate the cancer-protective properties of bio-identical progesterone.”

Why aren’t there more clinical studies investigating the safety and efficacy of bio-identical hormones? According to Dr. Randolph, it really boils down to two things: 1) lack of knowledge within the medical community because physicians have not been educated in medical school about the option of bio-identical hormone replacement and 2) the ability of major pharmaceutical companies to twist and manipulate the idea of hormone replacement to capitalize on a business opportunity.

“Synthetic hormones are produced in a lab and have a genetically modified structure, they can be patented.” Dr. Randolph said, “This allows big drug companies to market and sell this product exclusively, thus creating profits. Big pharmaceutical companies would not market, or fund research studies investigating, bio-identical hormones. Why should they? There is no way for them to make a buck on products that can’t be patented.”

“The pharmaceutical industry is the top funder of specialty forums and continuing medical education meetings for doctors. They offer physicians some nice “perks,” such as dinners, fishing trips and sporting event tickets. Credible or questionable, the dollars the pharmaceutical companies spend gets them the ear of the physician.”

It really comes down to business dollars versus patient care. The good news is that the consumer may soon have more power than the pharmaceutical industry. They now realize that they may be faced with a difficult decision when it comes to symptoms versus treatment. They are looking for alternatives because an all or nothing scenario doesn’t work for them.

“Smart, informed and demanding women are finding their voice and they want data that they can believe and trust,” concludes Dr. Randolph. “I believe every physician should embody their original role as patient advocate and demand that the safety and effectiveness of bio-identical hormones be a top priority for each medical university’s research agenda. The pharmaceutical industry’s marketing hype needs to be replaced with solid medical evidence. Bio-identical hormone replacement is a safe and effective option for women and men seeking treatment for hormone imbalances.”

Source: PR Web